Taxotere, manufactured by Sanofi Aventis, is an alternative chemotherapy drug that has lead to many documented cases of permanent hair loss,  known as alopecia.

 

While breast cancer is the most common cancer treated with Taxotere, it is also used for various other cancers such as prostate, lung, stomach and head/neck cancers.

 

The Problem with Taxotere

 

Taxotere was introduced to the market in the 90s as a less expensive alternative to Taxol, another chemotherapy drug. Taxotere was reportedly  as effective at cancer treatments, and with similar side effects, including temporary hair loss.

​

What became very clear however, is that many cancer survivors were not seeing their hair return at all, despite the drug company’s claims that hair loss was temporary. Even though temporary hair loss is a very common side effect of many chemotherapy treatments, permanent hair loss was not a side effect with  Taxol.

 

Additionally, there is strong evidence from multiple studies that points to alopecia being caused in patients who usedTaxotere as a chemotherapy treatment long before the FDA  recognized the issue in 2015.

 

The Purpose of this Lawsuit

 

The makers of Taxotere  did not disclose that their chemotherapy drug caused  alopecia. . 

​

While temporary hair loss may be an insignificant side effect to most, permanent hair loss is another issue. Alopecia can have a severe impact on a patient’s confidence and self-esteem which are crucial in the recovery process.   

 

Do I Have a Claim?

 

If you have received Taxotere as a chemotherapy treatment for your cancer, and then  experienced permanent hair loss, you  may call our legal experts  at 1-800-LAW-HELP for a free case evaluation to  determine if you qualify for financial compensation.

 

Our consultatants  will provide the answers you need in order to choose best how to  proceed. All conversations are completely confidential.​